Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Arita

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Anticancer Research|June 29, 2026
Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab <i>vs</i>. Sunitinib) for Advanced Renal Cell CarcinomaMotohiro Fujiwara, Soichiro Yoshida, Shugo Yajima, et al.
European Journal of Radiology Open|March 4, 2022
Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurementsYuki Arita, Hirotaka Akita, Hirokazu Fujiwara, et al.
Abdominal Radiology (New York)|June 19, 2026
Standardizing PSMA PET/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretationYuki Arita, Xinlin Zheng, Fang Wen, et al.
European Radiology|March 20, 2019
Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progressionShugo Yajima, Soichiro Yoshida, Taro Takahara, et al.
JCO Clinical Cancer Informatics|June 30, 2026
Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101Hiroshi Fukushima, Soichiro Yoshida, Shugo Yajima, et al.
Abdominal Radiology (New York)|June 27, 2026
Shifting from black box decisions to informed decision-making in using artificial intelligence to analyze prostate MRICharlie Alexander Hamm, Enyu Yuan, Georg Lukas Baumgärtner, et al.
Oncology|October 23, 2024
Development of an Artificial Intelligence System for Distinguishing Malignant from Benign Soft-Tissue Tumors Using Contrast-Enhanced MR ImagesToru Hirozane, Masahiro Hashimoto, Hasnine Haque, et al.
European Journal of Radiology|February 12, 2021
Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancerYuki Arita, Soichiro Yoshida, Yuma Waseda, et al.
European Radiology|August 24, 2020
Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitionsYuki Arita, Keisuke Shigeta, Hirotaka Akita, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|November 15, 2023
Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRISungmin Woo, Anton S Becker, Jeeban P Das, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Anticancer Research|June 29, 2026
Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab <i>vs</i>. Sunitinib) for Advanced Renal Cell CarcinomaMotohiro Fujiwara, Soichiro Yoshida, Shugo Yajima, et al.
European Journal of Radiology Open|March 4, 2022
Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurementsYuki Arita, Hirotaka Akita, Hirokazu Fujiwara, et al.
Abdominal Radiology (New York)|June 19, 2026
Standardizing PSMA PET/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretationYuki Arita, Xinlin Zheng, Fang Wen, et al.
European Radiology|March 20, 2019
Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progressionShugo Yajima, Soichiro Yoshida, Taro Takahara, et al.
JCO Clinical Cancer Informatics|June 30, 2026
Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101Hiroshi Fukushima, Soichiro Yoshida, Shugo Yajima, et al.
Abdominal Radiology (New York)|June 27, 2026
Shifting from black box decisions to informed decision-making in using artificial intelligence to analyze prostate MRICharlie Alexander Hamm, Enyu Yuan, Georg Lukas Baumgärtner, et al.
Oncology|October 23, 2024
Development of an Artificial Intelligence System for Distinguishing Malignant from Benign Soft-Tissue Tumors Using Contrast-Enhanced MR ImagesToru Hirozane, Masahiro Hashimoto, Hasnine Haque, et al.
European Journal of Radiology|February 12, 2021
Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancerYuki Arita, Soichiro Yoshida, Yuma Waseda, et al.
European Radiology|August 24, 2020
Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitionsYuki Arita, Keisuke Shigeta, Hirotaka Akita, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|November 15, 2023
Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRISungmin Woo, Anton S Becker, Jeeban P Das, et al.
Pageof 8